This would provide us with more valuable information about the clinical relevance of caspase-8 and the modified factors by caspase-8, which could be used as new drug targets to reduce the tumor-supportive properties of the TME and to improve the tumor response to the classical therapies. Here, CASP8 is linked to neoplasm.